BioSpace News Archive

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce it has partnered with EXCITE International (“EXCITE”), a global network of senior specialist physicians

Apotex Corp. has released its latest ophthalmic product in the United States, announcing today that brimonidine tartrate ophthalmic solution, 0.1% is now available.

NextCure, Inc. (Nasdaq: NXTC) today announced the presentation of preclinical data demonstrating that treatment with NC605, a novel anti-Siglec-15 (S15) antibody, reduced bone loss and enhanced bone formation and quality following immobilization in an experimental animal model of acute spinal cord injury (SCI), at the 2023 Military Health System Research Symposium (MHSRS).

Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that Linda Rubinstein, chief financial officer of Adverum Biotechnologies, will present at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023.

PhenomeX Inc. announced that Bruker Corporation has commenced, through its wholly owned subsidiary, Bird Mergersub Corporation, a cash tender offer to purchase all outstanding shares of common stock of PhenomeX for $1.00 per share.

Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted three newly-hired employees options to purchase an aggregate of 67,000 shares of Akebia’s common stock on August 31, 2023, as inducements material to such employee entering into employment with Akebia.

bluebird bio, Inc. announced that members of the management team will participate in fireside chats at the following upcoming investor conferences.